You've taken the words out of my mouth, Mr. Chair, but that's fine. You have it exactly.
I'll reiterate the point I made at the outset: On a simple fairness principle, we allow the various pharmaceutical companies to come and present their perspective, in addition to the trade associations that have also shared a view, naturally, as they have with the committee.
I should add that after the testimony is complete, we would move to a vote on our colleague's motion.
That's what we have to share, on our side.